Concepedia

Varsha Ananthapadmanabhan

VA

Statistics

Publications

4

Citations

163

H-Index

4

Active since

2018

Affiliations

Brigham and Women's Hospital(Current)

Harvard University

Dana-Farber Cancer Institute

Virginia Commonwealth University

Dana-Farber Brigham Cancer Center

Varsha Ananthapadmanabhan is an author at Brigham and Women's Hospital specializing in cell biology, medicine, and cell signaling.

ORCID

Top concepts

Publications per year

2018–2022

4

Publications

4

The cell cycle regulatory DREAM complex is disrupted by high expression of oncogenic B-Myb

Audra N. Iness, Jessica Felthousen, Varsha Ananthapadmanabhan et al. · Oncogene · 2018 · 70 citations · Full text

, , +9

DYRK1A regulates the recruitment of 53BP1 to the sites of DNA damage in part through interaction with RNF169

Vijay Menon, Varsha Ananthapadmanabhan, Selene K. Swanson et al. · Cell Cycle · 2019 · 49 citations · Full text

, , +14

Reversal of viral and epigenetic HLA class I repression in Merkel cell carcinoma

Patrick C. Lee, Susan Klaeger, Phuong M. Le et al. · Journal of Clinical Investigation · 2022 · 29 citations · Full text

Milademetan is a highly potent MDM2 inhibitor in Merkel cell carcinoma

Varsha Ananthapadmanabhan, Thomas C. Frost, Kara M. Soroko et al. · JCI Insight · 2022 · 15 citations · Full text

, , +16

1–4 of 4